The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Cancer Research

• Publication date

  2017-09-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-17-1789PMID 28954785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

  2017cited by this paper
• Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor.

  2016cited by this paper
• Genomic evolution and chemoresistance in germ-cell tumours

  2016cited by this paper
• Mature cystic teratomas arise from meiotic oocytes, but not from pre‐meiotic oogonia

  2016cited by this paper
• Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma

  2015cited by this paper
• Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.

  2015cited by this paper
• Comprehensive genomic characterization of head and neck squamous cell carcinomas

  2015cited by this paper
• Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Gynecologic Cancer InterGroup (GCIG) Consensus Review for Squamous Cell Carcinoma of the Ovary

  2014cited by this paper
• Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

  2014cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013influential reference
• Signatures of mutational processes in human cancer

  2013cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Can malignant transformation in mature cystic teratoma be preoperatively predicted?

  2012cited by this paper
• Temporal dissection of tumorigenesis in primary cancers.

  2011cited by this paper
• Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma

  2011cited by this paper
• Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data.

  2008cited by this paper
• HPV induced ovarian squamous cell carcinoma: case report and review of the literature

  2007cited by this paper
• Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues

  2005cited by this paper
• Dermoid cysts of the ovary with malignant transformation: MR appearance.

  1999cited by this paper
• Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin.

  1990cited by this paper
• Benign ovarian teratomas: a population-based case-control study.

  1988cited by this paper
• Parthenogenic origin of benign ovarian teratomas.

  1975cited by this paper

• Human Papillomavirus-Induced Keratinizing Squamous Cell Carcinoma in Ovarian Cystic Teratoma: A Case Report and Literature Review

  2026cites this paper
• Squamous Cell Carcinoma Arising from Mature Cystic Teratoma Treated by Immunotherapy: A Case Report

  2025cites this paper
• Establishment and characterization of preclinical model of primary ovarian squamous cell carcinoma

  2025cites this paper
• Potential Role of PTEN and AKT/PKB Proteins in the Pathogenesis of Ovarian Mature Teratomas

  2025cites this paper
• Somatic Malignancies Arising in Ovarian Mature Cystic Teratomas

  2025cites this paper
• Single‐Nucleus RNA Sequencing and Spatial Transcriptomics for Squamous Cell Carcinoma Arising From Ovarian Mature Teratoma

  2025cites this paper
• Mucinous Carcinoma, Mucinous Borderline Tumor and Pseudomyxoma Ovarii in a Cystic Teratoma: A Histological Conundrum

  2025cites this paper
• Metastatic squamous cell carcinoma arising from mature teratoma of the ovary: Description of multi-modality treatment including incorporation of adjuvant immunotherapy and maintenance PARP inhibitor therapy

  2024influential citation
• Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes

  2024influential citation
• Malignant transformation of an ovarian mature teratoma diagnosed 17 years ago: a case report and literature review of treatment with immune checkpoint inhibitors

  2024influential citation
• Molecular characterization of ovarian squamous cell carcinoma originating from mature teratoma

  2024cites this paper
• Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study

  2024cites this paper
• Genetic Profiling of Sebaceous Carcinoma Arising from an Ovarian Mature Teratoma: A Case Report

  2024cites this paper
• Successful treatment of advanced squamous cell carcinoma arising from mature cystic teratoma of the ovary with homologous recombination deficiency: A case report

  2023cites this paper
• Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.

  2023cites this paper
• Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report

  2023cites this paper
• Recurrent squamous cell carcinoma arising in ovary mature cystic teratoma: A case report

  2023cites this paper
• Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma

  2023cites this paper
• Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor

  2023cites this paper
• Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing

  2022cites this paper
• Case Report: Management of Recurrent Ovarian Squamous Cell Carcinoma With PD-1 Inhibitor

  2022cites this paper
• 30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease

  2022cites this paper
• Comprehensive analysis of the cancer driver genes constructs a seven-gene signature for prediction of survival and tumor immunity in hepatocellular carcinoma

  2022cites this paper
• DUSP5 and PHLDA1 mutations in mature cystic teratomas of the ovary identified on whole-exome sequencing may explain teratoma characteristics

  2022influential citation
• Nivolumab for malignant transformation of ovarian mature cystic teratoma

  2022influential citation
• The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma

  2022cites this paper
• FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections

  2021cites this paper
• NRG1 fusions in breast cancer

  2021cites this paper
• Downregulated miRNA-22-3p promotes the progression and leads to poor prognosis of hepatocellular carcinoma through targeting CDKN2C.

  2021cites this paper
• Incidental finding of malignant transformation of dermoid cyst in squamous cell carcinoma: a case report

  2021cites this paper
• Clonal evidence for the development of neuroblastoma with extensive copy‐neutral loss of heterozygosity arising in a mature teratoma

  2021cites this paper
• Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report

  2021cites this paper
• Squamous Cell Carcinoma Arising From a Mature Cystic Teratoma of the Ovary: A Case Report

  2021cites this paper
• Ovarian carcinosarcoma genomics and pre-clinical models highlight the N-MYC pathway as a key driver and susceptibility to EMT-targeting therapy

  2020cites this paper
• NRG1 fusions in breast cancer

  2020cites this paper
• Primary mucinous ovarian neoplasms rarely show germ cell histogenesis

  2020cites this paper
• Juvenile ovarian mature teratoma with malignant transformation diagnosed after laparoscopic surgery: A case report

  2020cites this paper
• Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database

  2020cites this paper
• Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature

  2020cites this paper
• XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary

  2020cites this paper
• Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

  2019cites this paper
• through following

  2019cites this paper
• Somatic mutations in intracranial arteriovenous malformations

  2019cites this paper
• Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review

  2019cites this paper
• FrenchFISH: Poisson models for quantifying DNA copy-number from fluorescence in situ hybridisation of tissue sections

  2018cites this paper